AmeriFlex Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9K Sell
255
-600
-70% -$28K 0.01% 672
2025
Q1
$29.1K Hold
855
0.01% 607
2024
Q4
$35.6K Buy
+855
New +$35.6K 0.02% 512